Ms. Quish is a Managing Director based in Menlo Park for the Fortress Credit Funds Business where she heads Asset Management for Fortress’s Intellectual Property Finance Group. In this role, she provides counsel and advice to portfolio companies that are engaged in monetization efforts. Ms. Quish has 20 years of experience assessing and monetizing patent assets. Prior to joining Fortress in 2018, Ms. Quish held the position of Vice President of Patent Strategy and M&A at Rovi Corporation, a TiVo Company where she was responsible for leading patent acquisitions and patent-heavy corporate acquisitions as well as designing and implementing IP monetization strategies. Prior to joining Rovi, Ms. Quish was a Member of Mintz Levin’s patent litigation practice where she spent the majority of her time representing patent owners in licensing and litigation matters including litigation in U.S. district courts and the International Trade Commission. Ms. Quish has been recognized by Intellectual Asset Magazine on a number of occasions, including being identified as one of the World’s Global Leaders in IP and the World’s Leading IP Strategists, where individuals are recognized for their experience related to creating and enforcing critical patent rights to help maximize the value of IP portfolios. In the past, Ms. Quish was also identified as one of the 40 world “Elite Dealmakers” and 1 of 10 “IP Personalities” by the same publication. Ms. Quish earned her J.D. from the University of Michigan Law School and her B.A. with High Honors from Middlebury College.
From the Courthouse Steps: Hikma v. Amarin
Adam Mossoff, Wesley Weeks
In Hikma Pharmaceuticals USA v. Amarin Pharma, the Supreme Court unanimously held that, to plausibly allege induced...
Litigation Transparency Act of 2025: Patents, Policy, and Legal Ethics
Kacie Donovan, Kristen Osenga, Courtney Quish, Jonathan Stroud, Paul Brian Taylor
Prompted by the reintroduction of federal Litigation Transparency Act legislation, this panel will address a...
Does Jarkesy Doom the Preserve Access to Affordable Generics and Biosimilars Act?
Matthew S. Hellman, William M. Jay, Emily Michiko Morris, Brian Pandya, Matthew D. Rowen
Reducing the cost of prescription drugs has been a bipartisan priority for years. One recent...
Patent Litigation in the Western District of Texas: An Afternoon Discussion with Judge Alan Albright and a New Take on Patent Case Procedures
Alan D. Albright, Arthur Gollwitzer, Ryan T. Holte
The Federalist Society’s Intellectual Property Practice Group will host a conversation with the Hon. Alan D. Albright of...
Patent Litigation in the Western District of Texas: An Afternoon Discussion with Judge Alan Albright and a New Take on Patent Case Procedures
TeleforumDoes Patent Litigation Need a Federal Solution? - Podcast
Jay Kesan, Eli Dourado
The America Invents Act, the first substantial legislative changes to patent law, took effect two...
Does Patent Litigation Need a Federal Solution?
TeleforumPatent Enforcement in the 21st Century
Boston Lawyers Chapter, Intellectual Property Practice Group, and Litigation Practice Group
Boston, MA